Live Breaking News & Updates on Simbec Research Ltd
Stay updated with breaking news from Simbec research ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oxford Cannabinoid Technologies Holdings PLC on Tuesday said it has successfully completed the dosing of all the cohorts of its Phase 1 study for its lead pharmaceutical asset, OCT461201.
Oxford Cannabinoid Technologies Holdings PLC on Monday said the final dose of its lead pharmaceutical drug compound, OCT461201, has been successfully administered.
Oxford Cannabinoid signs deal with Simbec for trial on neuropathy drug lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.